Skip to main content
. 2021 Jun 24;64(13):9042–9055. doi: 10.1021/acs.jmedchem.1c00158

Table 1. Pharmacological Data of Helianorphins at the KORa.

    affinity potency/efficacy cAMP  
ligand sequence* Ki ± SD (M) EC50 ± SD (M) Emax ± SD (%)
dyn A 1–13 YGGFLRRIRPKLK-NH2 3.1 ± 0.3 × 10–10 2.8 ± 0.7 × 10–9 100
SFTI-1 c-CTKSIPPICFPDGR >3.0 × 10–5 n.d. n.d.
helianorphin-1 c-CYGGFLRRIRPKLKCFPDGR 2.2 ± 0.6 × 10–7 1.7 ± 0.1 × 10–6 106 ± 8.4
helianorphin-2 c-CTKSIPPICYGGFLRRIRPKLK 9.7 ± 0.5 × 10–8 1.3 ± 0.4 × 10–6 102 ± 10
helianorphin-3 c-CYGGFLRRICFPDGR 3.2 ± 0.4 × 10–6 1.4 ± 0.3 × 10–6 85.1 ± 1.8
helianorphin-4 c-CTKSIPPICYGGFLRRI 2.5 ± 0.05 × 10–6 4.7 ± 1.3 × 10–6 87.8 ± 33
helianorphin-5 c-CYGGFLRICFPDGR >10–5 n.d. n.d.
helianorphin-6 c-CTYGGFLRCFPDGR >10–5 n.d. n.d.
helianorphin-7 c-CTASIPPICYGGFLR >10–5 n.d. n.d.
helianorphin-8 c-CTYGGFPICFPDGR >10–5 n.d. n.d.
helianorphin-9 c-CTASIPPICYGGFR >10–5 n.d. n.d.
helianorphin-10 c-CTfflkPICFPDGR >10–5 n.d. n.d.
helianorphin-11 c-CTASIPPICfflkR >10–5 n.d. n.d.
helianorphin-12 c-CTffbrPICFPDGR 2.3 ± 0.5 × 10–6 1.5 ± 0.3 × 10–6 117 ± 12
helianorphin-13 c-CTASIPPICffbrR >10–5 n.d. n.d.
helianorphin-14 c-CYGGFLRRIRpKLKCFPDGR 2.2 ± 0.3 × 10–7 n.d. n.d.
helianorphin-15 c-CffbrLRRIRPKLKCFPDGR 1.7 ± 0.1 × 10–7 n.d. n.d.
helianorphin-16 c-CTASIPPICffbrLRRIRPKLK 2.5 ± 0.2 × 10–7 n.d. n.d.
helianorphin-17 c-CTASIPPICffbrLRRIRpKLK 1.2 ± 0.5 × 10–7 n.d. n.d.
helianorphin-18 c-CTYGGFLRCRIRPKLK 6.5 ± 1.5 × 10–7 n.d. n.d.
helianorphin-19 c-CYGGFLRRCIRPKLK 2.1 ± 0.8 × 10–8 4.5 ± 0.6 × 10–8 108 ± 11
a

Data are from three to six independent biological replicates. *Grafted epitopes are underlined; lysine (K) was replaced with alanine (A) to abolish trypsin inhibitory activity and is shown in the italic font; f, l, k, b, and r denote D-enantiomers of phenylalanine, leucine, lysine, norleucine, and arginine, respectively. n.d., not determined; dyn A, dynorphin A; and SFTI, sunflower trypsin inhibitor.